Loredana Correale

ORCID: 0000-0003-1646-5219
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Digital Radiography and Breast Imaging
  • AI in cancer detection
  • Global Cancer Incidence and Screening
  • Renal function and acid-base balance
  • Colorectal Cancer Screening and Detection
  • Gallbladder and Bile Duct Disorders
  • Neonatal Health and Biochemistry
  • Metastasis and carcinoma case studies
  • Pancreatitis Pathology and Treatment
  • Cancer and Skin Lesions
  • Mercury impact and mitigation studies
  • Artificial Intelligence in Healthcare and Education
  • Radiomics and Machine Learning in Medical Imaging
  • Sulfur Compounds in Biology
  • Pediatric Hepatobiliary Diseases and Treatments
  • Medical Imaging and Pathology Studies
  • Advanced X-ray and CT Imaging
  • Colorectal Cancer Treatments and Studies
  • Chemical Analysis and Environmental Impact
  • Systemic Sclerosis and Related Diseases
  • Colorectal Cancer Surgical Treatments
  • Ultrasound and Hyperthermia Applications
  • Prostate Cancer Diagnosis and Treatment
  • Gastrointestinal Tumor Research and Treatment

IRCCS Humanitas Research Hospital
2020-2025

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino
2022-2024

Piedmont Reference Center for Epidemiology and Cancer Prevention
2024

Agostino Gemelli University Polyclinic
2021

Ospedale Regina Margherita
2020

University of Bologna
2019

Torino e-district
2015

Objective To evaluate the sensitivity of multiparametric magnetic resonance imaging (mp‐ MRI ) for detecting prostate cancer foci, including largest (index) lesions. Patients and Methods In all, 115 patients with biopsy confirmed underwent mp‐ before radical prostatectomy. A single expert radiologist recorded all foci index lesion ‘blinded’ to pathologist's report. Stained whole‐mount histological sections were used as reference standard. All lesions contoured by an experienced...

10.1111/bju.13234 article EN BJU International 2015-07-20
Paolo Giorgi Rossi Pamela Mancuso Pierpaolo Pattacini Cinzia Campari Andrea Nitrosi and 95 more Valentina Iotti Antonio Ponti Alfonso Frigerio Loredana Correale Emilia Riggi Livia Giordano Nereo Segnan Giovanni Di Leo Veronica Magni Francesco Sardanelli Francesca Fornasa Giovanna Romanucci Stefania Montemezzi Patrizia Falini Noemi Auzzi Marco Zappa Marta Ottone Paola Mantellini Stephen W. Duffy Paola Armaroli Chiara Coriani Manuela Pescarolo Gloria Stefanelli Giulio Tondelli Filippo Beretti Sabrina Caffarri Vanessa Marchesi Laura Canovi Marco Colli Mirco Boschini Marco Bertolini Moira Ragazzi Pierpaolo Pattacini Paolo Giorgi Rossi Valentina Iotti Vladimiro Ginocchi Sara Ravaioli Rita Vacondio Cinzia Campari Stefania Caroli Andrea Nitrosi Luca Braglia Silvio Cavuto Pamela Mancuso Olivera Djurić Francesco Venturelli Massimo Vicentini Maria Barbara Braghiroli Jasmine Lonetti Elena Davoli Efrem Bonelli Francesca Fornasa Stefania Montemezzi Giovanna Romanucci Ilaria Lucchi Gessica Martello Claudia Rossati Paola Mantellini Daniela Ambrogetti Anna Iossa Eva Carnesciali Vincenzo Mazzalupo Patrizia Falini Donella Puliti Marco Zappa Francesca Battisti Noemi Auzzi Simona Verdi Carolina Degl’Innocenti Daniela Tramalloni Elena Cavazza S. Busoni Elisa Betti Francesca Peruzzi Francesco Regini Francesco Sardanelli Giovanni Di Leo Luca Alessandro Carbonaro Veronica Magni Andrea Cozzi D. Spinelli Cristian Giuseppe Monaco Simone Schiaffino Adrienn Benedek Laura Menicagli Raffaella Ferraris Elisabetta Favettini Davide Dettori P. Di Falco Pietro Presti Nereo Segnan Antonio Ponti Alfonso Frigerio Paola Armaroli Loredana Correale

10.1016/j.ejca.2024.113553 article EN European Journal of Cancer 2024-01-21

Proteus Donna is a randomised controlled trial aimed at prospectively evaluating screening with digital breast tomosynthesis (DBT), including interval cancer detection (ICD) and (CD) in the analysis as cumulative measure over subsequent episodes. Consenting women aged 46 to 68 attending regional Breast Screening Service were randomly assigned conventional mammography (DM, control arm) or DBT addition DM (DBT, study arm). At round all participants underwent DM. Thirty-six months follow-up...

10.1002/ijc.34161 article EN International Journal of Cancer 2022-06-11

Background: Guidelines suggest using tomosynthesis (DBT) as an alternative to digital mammography (DM) for screening but certainty of evidence on its efficacy is very low. This study aims compare performance with DBT versus DM.Methods: MAITA a consortium four Italian trials, REtomo, Proteus, Impeto, and trial, conducted in 20 clinics from 5 organized programs. The trials adopted two-arm randomized design comparing plus DM (REtomo Proteus) or synthetic-2D (Impeto trial) DM; multiple vendors...

10.2139/ssrn.4508422 preprint EN 2023-01-01
Coming Soon ...